Clinical Trial Update: TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating the TENDU vaccine in patients with prostate cancer that relapsed after radical p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TENDU vaccine

Snippet

Sponsor: Ultimovacs ASA | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED